New research reveals that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional lifestyle programs.
Research printed in a leading health publication demonstrates that while obese people can lose a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People using these drugs need to be informed of the potential of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment mass within about one and a half years.
Weighing Approaches
The study, which examined dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with older methods.
Scientists point out that individuals who lose weight through dieting typically see a less rapid weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists believe the way of the jabs is key to understanding the amplified weight return.
GLP-1 drugs mimic a body's own chemical called GLP-1, which controls appetite.
"Long-term administration of the hormone concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' results in appetite is uncontrolled, making excessive eating much more probable."
A Lifelong Condition?
Health authorities suggest the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals argue that, considering the significant potential of relapse, the therapy might need to be long-term.
This opinion is reinforced by drug manufacturers, who note that the findings "emphasize the long-term character of excess weight," akin to managing conditions like hypertension.
User Experiences
People who have stopped the medication describe a intense return of hunger.
"It felt as if something flipping and you become extremely hungry," recalled a patient.
This difficulty is compounded if users have not established lasting lifestyle or habit changes during treatment.
Widespread Use
Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Adoption is higher among females than men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while these medications are powerful agents for weight loss, they are not a permanent cure and lasting health benefits relies on integrated lifestyle management.